tiprankstipranks
Advertisement
Advertisement

RGNX Stock Latest News

Acting FDA head vows to block political interference, Endpoint News says
The FlyActing FDA head vows to block political interference, Endpoint News says
2h ago
AZN
BMY
RegenXBio Launches Targeted Employee Stock Option Exchange
PremiumCompany Announcements
RegenXBio Launches Targeted Employee Stock Option Exchange
1d ago
8K
RGNX
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
2d ago
AZN
BMY
RegenXbio’s RGX-202 Pivotal Win Lifts Outlook
PremiumCompany Announcements
RegenXbio’s RGX-202 Pivotal Win Lifts Outlook
16d ago
RGNX
RegenXBio’s Earnings Call Signals Pivotal Gene-Therapy Win
PremiumCompany Announcements
RegenXBio’s Earnings Call Signals Pivotal Gene-Therapy Win
17d ago
RGNX
Regenxbio price target lowered to $16 from $17 at Morgan Stanley
PremiumThe FlyRegenxbio price target lowered to $16 from $17 at Morgan Stanley
20d ago
RGNX
Regenxbio price target lowered to $14 from $25 at BofA
Premium
The Fly
Regenxbio price target lowered to $14 from $25 at BofA
20d ago
RGNX
Regenxbio price target lowered to $12 from $37 at Barclays
Premium
The Fly
Regenxbio price target lowered to $12 from $37 at Barclays
20d ago
RGNX
Midday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
PremiumThe Fly
Midday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
21d ago
AEM
FNV
Regenxbio reports Q1 EPS ($1.72) vs. 12c last year
PremiumThe Fly
Regenxbio reports Q1 EPS ($1.72) vs. 12c last year
21d ago
RGNX
Regenxbio expects cash, equivalents to fund operations into early 2027
PremiumThe Fly
Regenxbio expects cash, equivalents to fund operations into early 2027
21d ago
RGNX
Regenxbio’s RGX-202 shows efficacy in Phase 3 Duchenne trial
PremiumThe Fly
Regenxbio’s RGX-202 shows efficacy in Phase 3 Duchenne trial
21d ago
RGNX
RegenXBio Advances RGX-202 With Positive Phase III Results
PremiumCompany AnnouncementsRegenXBio Advances RGX-202 With Positive Phase III Results
21d ago
8K
RGNX
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
Premium
The Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
23d ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
24d ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
24d ago
DYN
RNA
RGNX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RGNX Upcoming Earnings Report: What to Expect?
1M ago
RGNX
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
PremiumThe Fly
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
1M ago
BA
BE
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
2M ago
DYN
RNA
Shareholders Sue RGNX Over Gene Therapy Study Claims
PremiumMarket NewsShareholders Sue RGNX Over Gene Therapy Study Claims
2M ago
RGNX
RegenXBio Reaches Settlement with GSK Over License Fees
Premium
Company Announcements
RegenXBio Reaches Settlement with GSK Over License Fees
3M ago
8K
RGNX
REGENXBIO Faces Federal Securities Lawsuit Over Allegedly Concealed Gene Therapy Safety Risks
Premium
Class Action
REGENXBIO Faces Federal Securities Lawsuit Over Allegedly Concealed Gene Therapy Safety Risks
3M ago
RGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >